SDF-1/CXCL12: its role in spinal cord injury

Int J Biochem Cell Biol. 2012 Mar;44(3):452-6. doi: 10.1016/j.biocel.2011.11.023. Epub 2011 Dec 8.

Abstract

The chemokine stromal cell-derived factor 1 (SDF-1/CXCL12), is not only the most ancient, but also one of the most potent chemotactic factors. Orchestrating the migration of cells as well as promoting axon outgrowth in the presence of myelin inhibitors, SDF-1 is fundamental to central nervous system development, homeostasis and traumatic injury. SDF-1 attracts endogenous stem/precursor cells and immune cells to the injury site and, upon local infusion, enhances axonal sprouting following spinal cord injury. Together these features make SDF-1 a very exciting molecule for spinal cord repair.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Axons / physiology*
  • Cell Movement / genetics
  • Chemokine CXCL12 / genetics
  • Chemokine CXCL12 / metabolism*
  • Chemotaxis / genetics
  • Humans
  • Molecular Targeted Therapy
  • Spinal Cord Injuries / drug therapy
  • Spinal Cord Injuries / genetics
  • Spinal Cord Injuries / metabolism*
  • Spinal Cord Injuries / pathology

Substances

  • CXCL12 protein, human
  • Chemokine CXCL12